“…This type of approach includes the recent finding that in human lymphoid secondary follicles, in both lymph nodes and tonsillar tissue, DRC express one type of immunoreactive cysteine-proteinase inhibitor, namely acid cysteine-proteinase inhibitor (ACPI) (Rinne et al, 1981(Rinne et al, , 1983; Alavaikko et al, in press). Its biochemical characteristics include: molecular weight 12,000, isoelectric point 4.6-5.0, heat stability and inhibition of cathepsins B and H, papain, ficin and bromelain (Jarvinen, 1978;Jarvinen and Rinne, 1982). It is of particular interest that ACPI was originally isolated and purified from human epidermis (Jarvinen, 1978) and seems to be a constant characteristic of human squamous epithelia (Rinne et al, 1978).…”